Kwangdong Healthbio Market Cap

Kwangdong Healthbio has a market cap or net worth of 17 billion as of February 2, 2026. Its market cap has decreased by -2.85% in one year.

Market Cap

17.00B

Enterprise Value

n/a

Revenue

38.10B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,340.00

Market Cap Chart

Since April 5, 2017, Kwangdong Healthbio's market cap has decreased from 20.68B to 17.00B, a decrease of -17.77%. That is a compound annual growth rate of -2.19%.

Market Cap History

Date	Market Cap	% Change
Feb 2, 2026	17.00B	-14.87%
Dec 30, 2025	19.97B	14.12%
Dec 30, 2024	17.50B	-38.70%
Dec 28, 2023	28.55B	23.01%
Dec 29, 2022	23.21B	-12.02%
Dec 30, 2021	26.38B	-4.04%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Seoul Pharma	33.40B
Pharmsville	28.13B
Daesung Microbiological Labs.	28.12B
ChoA Pharmaceutical Co., LTD.	27.97B
Hurum	25.16B
BIFIDO	24.25B
WooGene B&G	22.88B
Union Korea Pharm	19.70B

Market Cap Rankings